Stock CTKB CYTEK BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Real-time Estimate Cboe BZX
Other stock markets
 03:29:49 2024-05-23 pm EDT 		5-day change 1st Jan Change
5.865 USD -1.76% Intraday chart for Cytek Biosciences, Inc. -5.18% -35.75%
May. 20 Cytek Biosciences, Inc. Adds Ability to Detect Subcellular Particles to Its Cell Analysis Systems CI
May. 13 Piper Sandler Adjusts Price Target on Cytek Biosciences to $8.50 From $10, Maintains Overweight Rating MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytek Biosciences, Inc. Adds Ability to Detect Subcellular Particles to Its Cell Analysis Systems
Cytek Biosciences, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024
Cytek Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University
Cytek Biosciences, Inc. Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
Cytek Seeks Merger and Acquisitions
Cytek Biosciences, Inc. Provides Revenue Guidance for the Year 2023
Cytek Biosciences Introduces the Cytek Orion? Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
Cytek Biosciences Insider Sold Shares Worth $120,600, According to a Recent SEC Filing
Cytek Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Cytek Biosciences, Inc. Provides Revenue Guidance for the Year 2023
Cytek Biosciences Insider Sold Shares Worth $106,600, According to a Recent SEC Filing
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. News Cytek Biosciences, Inc.
  5. Other languages